Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 5079597, 9 pages
http://dx.doi.org/10.1155/2016/5079597
Research Article

An EP2 Agonist Facilitates NMDA-Induced Outward Currents and Inhibits Dendritic Beading through Activation of BK Channels in Mouse Cortical Neurons

1Department of Aging Science and Pharmacology, Faculty of Dental Sciences, Kyushu University, Fukuoka 812-8582, Japan
2Department of Dental Anesthesiology, Faculty of Dental Sciences, Kyushu University, Fukuoka 812-8582, Japan
3Institute for Metabolic and Neuropsychiatric Disorders, Binzhou Medical University, Binzhou 256603, China

Received 26 February 2016; Revised 19 April 2016; Accepted 4 May 2016

Academic Editor: Hermann Gram

Copyright © 2016 Yoshinori Hayashi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Zhang, J. Yamada, Y. Hayashi, Z. Wu, S. Koyama, and H. Nakanishi, “Inhibition of NMDA-induced outward currents by interleukin-1β in hippocampal neurons,” Biochemical and Biophysical Research Communications, vol. 372, no. 4, pp. 816–820, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Zhang, L. Sun, Y. Hayashi et al., “Acute p38-mediated inhibition of NMDA-induced outward currents in hippocampal CA1 neurons by interleukin-1β,” Neurobiology of Disease, vol. 38, no. 1, pp. 68–77, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Katafuchi, S. Duan, S. Take, and M. Yoshimura, “Modulation of glutamate-induced outward current by prostaglandin E2 in rat dissociated preoptic neurons,” Brain Research, vol. 1037, no. 1-2, pp. 180–186, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Sugimoto and S. Narumiya, “Prostaglandin E receptors,” The Journal of Biological Chemistry, vol. 282, no. 16, pp. 11613–11617, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. L. McCullough, L. Wu, N. Haughey et al., “Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia,” The Journal of Neuroscience, vol. 24, no. 1, pp. 257–268, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Jiang, T. Ganesh, Y. Du et al., “Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 5, pp. 2307–2312, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Liu, L. Wu, R. Breyer, M. P. Mattson, and K. Andreasson, “Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia,” Annals of Neurology, vol. 57, no. 5, pp. 758–761, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Ahmad, S. Saleem, Z. Shah, T. Maruyama, S. Narumiya, and S. Doré, “The PGE2 EP2 receptor and its selective activation are beneficial against ischemic stroke,” Experimental and Translational Stroke Medicine, vol. 2, no. 1, article 12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. G. E. Hardingham, Y. Fukunaga, and H. Bading, “Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways,” Nature Neuroscience, vol. 5, no. 5, pp. 405–414, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Jiang, Y. Quan, T. Ganesh, W. A. Pouliot, F. E. Dudek, and R. Dingledine, “Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 9, pp. 3591–3596, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Hayashi, H. Ishibashi, K. Hashimoto, and H. Nakanishi, “Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors,” Glia, vol. 53, no. 6, pp. 660–668, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. J. S. Isaacson and G. J. Murphy, “Glutamate-mediated extrasynaptic inhibition: direct coupling of NMDA receptors to Ca2+-activated K+ channels,” Neuron, vol. 31, no. 6, pp. 1027–1034, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. M. J. Hasbani, M. L. Schlief, D. A. Fisher, and M. P. Goldberg, “Dendritic spines lost during glutamate receptor activation reemerge at original sites of synaptic contact,” The Journal of Neuroscience, vol. 21, no. 7, pp. 2393–2403, 2001. View at Google Scholar · View at Scopus
  14. J. Zhang and S. Rivest, “Distribution, regulation and colocalization of the genes encoding the EP2- and EP4-PGE2 receptors in the rat brain and neuronal responses to systemic inflammation,” European Journal of Neuroscience, vol. 11, no. 8, pp. 2651–2668, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Kiriyama, F. Ushikubi, T. Kobayashi, M. Hirata, Y. Sugimoto, and S. Narumiya, “Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells,” British Journal of Pharmacology, vol. 122, no. 2, pp. 217–224, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Saeki, T. Ota, M. Aihara, and M. Araie, “Effects of prostanoid EP agonists on mouse intraocular pressure,” Investigative Ophthalmology and Visual Science, vol. 50, no. 5, pp. 2201–2208, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Akram, C. L. Gibson, and B. D. Grubb, “Neuroprotection mediated by the EP4 receptor avoids the detrimental side effects of COX-2 inhibitors following ischaemic injury,” Neuropharmacology, vol. 65, pp. 165–172, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Echeverria, A. Clerman, and S. Doré, “Stimulation of PGE2 receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following β-amyloid exposure,” European Journal of Neuroscience, vol. 22, no. 9, pp. 2199–2206, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Candelario-Jalil, H. Slawik, I. Ridelis et al., “Regional distribution of the prostaglandin E2 receptor EP1 in the rat brain: accumulation in Purkinje cells of the cerebellum,” Journal of Molecular Neuroscience, vol. 27, no. 3, pp. 303–310, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Zhang and S. Rivest, “A functional analysis of EP4 receptor-expressing neurons in mediating the action of prostaglandin E2 within specific nuclei of the brain in response to circulating interleukin-1β,” Journal of Neurochemistry, vol. 74, no. 5, pp. 2134–2145, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Yamaguchi, T. Kubota, S. Watanabe, and T. Yamamoto, “Activation of brain prostanoid EP3 receptors via arachidonic acid cascade during behavioral suppression induced by Δ8-tetrahydrocannabinol,” Journal of Neurochemistry, vol. 88, no. 1, pp. 148–154, 2004. View at Google Scholar · View at Scopus
  22. Y. Ikeda-Matsuo, H. Tanji, A. Ota et al., “Microsomal prostaglandin e synthase-1 contributes to ischaemic excitotoxicity through prostaglandin E2 EP3 receptors,” British Journal of Pharmacology, vol. 160, no. 4, pp. 847–859, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. B. P. Bean, “The action potential in mammalian central neurons,” Nature Reviews Neuroscience, vol. 8, no. 6, pp. 451–465, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. X.-B. Zhou, I. Wulfsen, E. Utku et al., “Dual role of protein kinase C on BK channel regulation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 17, pp. 8005–8010, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. H. A. Widmer, I. C. M. Rowe, and M. J. Shipston, “Conditional protein phosphorylation regulates BK channel activity in rat cerebellar Purkinje neurons,” Journal of Physiology, vol. 552, no. 2, pp. 379–391, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. W. A. Kaufmann, Y. Kasugai, F. Ferraguti, and J. F. Storm, “Two distinct pools of large-conductance calcium-activated potassium channels in the somatic plasma membrane of central principal neurons,” Neuroscience, vol. 169, no. 3, pp. 974–986, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. W. A. Kaufmann, F. Ferraguti, Y. Fukazawa et al., “Large-conductance calcium-activated potassium channels in Purkinje cell plasma membranes are clustered at sites of hypolemmal microdomains,” Journal of Comparative Neurology, vol. 515, no. 2, pp. 215–230, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. S. M. Greenwood, S. M. Mizielinska, B. G. Frenguelli, J. Harvey, and C. N. Connolly, “Mitochondrial dysfunction and dendritic beading during neuronal toxicity,” The Journal of Biological Chemistry, vol. 282, no. 36, pp. 26235–26244, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Liu, T. P. Wong, M. Aarts et al., “NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo,” The Journal of Neuroscience, vol. 27, no. 11, pp. 2846–2857, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Paoletti, C. Bellone, and Q. Zhou, “NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease,” Nature Reviews Neuroscience, vol. 14, no. 6, pp. 383–400, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. G. E. Serrano, N. Lelutiu, A. Rojas et al., “Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus,” The Journal of Neuroscience, vol. 31, no. 42, pp. 14850–14860, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. J. U. Johansson, S. Pradhan, L. A. Lokteva et al., “Suppression of inflammation with conditional deletion of the prostaglandin E2 EP2 receptor in macrophages and brain microglia,” The Journal of Neuroscience, vol. 33, no. 40, pp. 16016–16032, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. J. U. Johansson, N. S. Woodling, Q. Wang et al., “Prostaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models,” The Journal of Clinical Investigation, vol. 125, no. 1, pp. 350–364, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Zhang, X. Gong, G. Hu, and X. Wang, “EP2-PKA signaling is suppressed by triptolide in lipopolysaccharide-induced microglia activation,” Journal of Neuroinflammation, vol. 12, no. 1, article 50, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Terada, J. Yamada, Y. Hayashi et al., “Involvement of cathepsin B in the processing and secretion of interleukin-1β in chromogranin a-stimulated microglia,” Glia, vol. 58, no. 1, pp. 114–124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. X. Sun, D. Zhou, P. Zhang, E. G. Moczydlowski, and G. G. Haddad, “β-subunit-dependent modulation of hSlo BK current by arachidonic acid,” Journal of Neurophysiology, vol. 97, no. 1, pp. 62–69, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Hayashi, M. Yoshida, M. Yamato et al., “Reverse of age-dependent memory impairment and mitochondrial DNA damage in microglia by an overexpression of human mitochondrial transcription factor A in mice,” The Journal of Neuroscience, vol. 28, no. 34, pp. 8624–8634, 2008. View at Publisher · View at Google Scholar · View at Scopus